An Open-Label Study Evaluating the Long-Term Efficacy, Quality of Life, and Safety of Lidose-Isotretinoin (ABSORICA) Capsules Administered Without Food in Patients with Severe Recalcitrant Nodular Acne: Interim Analysis of 20-Week Active Treatment Period

Andrea Zaenglein, James Del Rosso

Abstract


Abstract not available.

 

Disclosures: Study supported by SUN Pharma.

 

Copyright 2018 SKIN


Keywords


acne; nodular acne; lidose-isotretinoin; retinoid

Full Text: Poster PDF

DOI: 10.25251/skin.2.supp.32

Abstract - 223 Poster PDF - 40

Refbacks

  • There are currently no refbacks.

ISSN: 2574-1624

x
Message